Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone

NCT02603926 is registered in ClinicalTrials.gov with Randi J. Hagerman, MD as lead sponsor.

NCT NCT02603926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02603926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
Lead sponsor
Randi J. Hagerman, MD
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
December 31, 2017
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x-associated tremor/ataxia syndrome